178 related articles for article (PubMed ID: 33586069)
1. Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database.
Baechle JJ; Marincola Smith P; Solórzano CC; Tran TB; Postlewait LM; Maithel SK; Prescott J; Pawlik T; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin L; Abbott DE; Ronnekleiv-Kelly S; Sicklick JK; Yopp A; Mansour J; Duh QY; Seiser N; Votanopoulos K; Levine EA; Poultsides G; Kiernan CM
Ann Surg Oncol; 2021 Oct; 28(11):6551-6561. PubMed ID: 33586069
[TBL] [Abstract][Full Text] [Related]
2. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of 'GRAS' parameters in stage I-III adrenocortical carcinomas: long-term data from a high-volume institution.
Liang J; Liu Z; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Wei X; Lu Y; Zhu Y
Endocrine; 2020 Feb; 67(2):449-456. PubMed ID: 31786772
[TBL] [Abstract][Full Text] [Related]
4. Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study.
Lippert J; Dischinger U; Appenzeller S; Prete A; Kircher S; Skordilis K; Elhassan YS; Altieri B; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2023 Aug; 189(2):262-270. PubMed ID: 37590967
[TBL] [Abstract][Full Text] [Related]
5. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
6. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
[TBL] [Abstract][Full Text] [Related]
7. Assessment of prognostic factors in pediatric adrenocortical tumors: a systematic review and evaluation of a modified S-GRAS score.
Riedmeier M; Decarolis B; Haubitz I; Reibetanz J; Wiegering A; Härtel C; Schlegel PG; Fassnacht M; Wiegering V
Eur J Endocrinol; 2022 Dec; 187(6):751-763. PubMed ID: 36193775
[TBL] [Abstract][Full Text] [Related]
8. Role of Additional Organ Resection in Adrenocortical Carcinoma: Analysis of 167 Patients from the U.S. Adrenocortical Carcinoma Database.
Marincola Smith P; Kiernan CM; Tran TB; Postlewait LM; Maithel SK; Prescott J; Pawlik T; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay J; Shirley LA; Fields RC; Jin L; Weber S; Salem A; Sicklick J; Gad S; Yopp A; Mansour J; Duh QY; Seiser N; Votanopoulos K; Levine EA; Poultsides G; Solórzano CC
Ann Surg Oncol; 2018 Aug; 25(8):2308-2315. PubMed ID: 29868977
[TBL] [Abstract][Full Text] [Related]
9. Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma.
Liu J; Lin W; Yan L; Xie J; Dai J; Xu D; Zhao J
Endocrine; 2024 Mar; 83(3):763-774. PubMed ID: 37968537
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
[TBL] [Abstract][Full Text] [Related]
12. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
[TBL] [Abstract][Full Text] [Related]
13. Impact of Micro- and Macroscopically Positive Surgical Margins on Survival after Resection of Adrenocortical Carcinoma.
Anderson KL; Adam MA; Thomas SM; Youngwirth L; Stang MT; Scheri RP; Roman SA; Sosa JA
Ann Surg Oncol; 2018 May; 25(5):1425-1431. PubMed ID: 29500765
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.
Morimoto R; Satoh F; Murakami O; Suzuki T; Abe T; Tanemoto M; Abe M; Uruno A; Ishidoya S; Arai Y; Takahashi K; Sasano H; Ito S
Endocr J; 2008 Mar; 55(1):49-55. PubMed ID: 18187873
[TBL] [Abstract][Full Text] [Related]
16. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Targeted Methylation Analysis in Paraffin-embedded Samples of Adrenocortical Carcinoma.
Lippert J; Altieri B; Morrison B; Steinhauer S; Smith G; Lorey A; Urlaub H; Kircher S; Sitch A; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2022 Sep; 107(10):2892-2899. PubMed ID: 35929659
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma.
Luconi M; Cantini G; van Leeuwaarde RS; Roebaar R; Fei L; Propato AP; Santi R; Ercolino T; Mannelli M; Canu L; de Krijger RR; Nesi G
Endocr Pathol; 2023 Jun; 34(2):224-233. PubMed ID: 36952130
[TBL] [Abstract][Full Text] [Related]
19. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
[TBL] [Abstract][Full Text] [Related]
20. Disparities in access to care and outcomes in patients with adrenocortical carcinoma.
Hammad AY; Yen TWF; Carr AA; Evans DB; Wang TS
J Surg Res; 2017 Jun; 213():138-146. PubMed ID: 28601306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
